Shanghai Pharma Increases IPO Offering By Half On HK Market
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceuticals Holding increased its initial public offering on the Hong Kong Stock Exchange by 50%, to $1.8 billion, a source said